Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumihiko Mabuchi

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Retina (Philadelphia, Pa.)|November 10, 2009
Angiographic lesion size associated with LOC387715 A69S genotype in subfoveal polypoidal choroidal vasculopathyYoichi Sakurada, Takeo Kubota, Mitsuhiro Imasawa, et al.
Scientific Reports|November 30, 2017
Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathyWataru Kikushima, Yoichi Sakurada, Atsushi Sugiyama, et al.
Japanese Journal of Ophthalmology|May 19, 2026
Genetic factors associated with response to as-needed brolucizumab treatment for exudative age-related macular degenerationSeigo Yoneyama, Yoichi Sakurada, Yoshiko Fukuda, et al.
Journal of Glaucoma|December 11, 2012
Comparison of a remote operating slit-lamp microscope system with a conventional slit-lamp microscope system for examination of trabeculectomy eyesKenji Kashiwagi, Naohiko Tanabe, Kentaro Go, et al.
Scientific Reports|March 8, 2017
Incidence and risk factors of retreatment after three-monthly aflibercept therapy for exudative age-related macular degenerationWataru Kikushima, Yoichi Sakurada, Seigo Yoneyama, et al.
Journal of Glaucoma|October 16, 2008
High prevalence of anxiety and depression in patients with primary open-angle glaucomaFumihiko Mabuchi, Kimio Yoshimura, Kenji Kashiwagi, et al.
Retina (Philadelphia, Pa.)|January 9, 2016
GENETIC FACTORS ASSOCIATED WITH CHOROIDAL VASCULAR HYPERPERMEABILITY AND SUBFOVEAL CHOROIDAL THICKNESS IN POLYPOIDAL CHOROIDAL VASCULOPATHYSeigo Yoneyama, Yoichi Sakurada, Wataru Kikushima, et al.
Genes|July 29, 2025
Genetic Factors Associated with Intraocular Inflammation After Brolucizumab Administration in Patients with Exudative Age-Related Macular DegenerationSeigo Yoneyama, Yoichi Sakurada, Taiyo Shijo, et al.
Ophthalmic Genetics|September 3, 2015
Risk Factors for Second Eye Involvement in Eyes with Unilateral Polypoidal Choroidal VasculopathyYasushi Tateno, Yoichi Sakurada, Seigo Yoneyama, et al.
Ophthalmic Research|December 5, 2014
Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degenerationYoichi Sakurada, Yuki Nakamura, Seigo Yoneyama, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Retina (Philadelphia, Pa.)|November 10, 2009
Angiographic lesion size associated with LOC387715 A69S genotype in subfoveal polypoidal choroidal vasculopathyYoichi Sakurada, Takeo Kubota, Mitsuhiro Imasawa, et al.
Scientific Reports|November 30, 2017
Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathyWataru Kikushima, Yoichi Sakurada, Atsushi Sugiyama, et al.
Japanese Journal of Ophthalmology|May 19, 2026
Genetic factors associated with response to as-needed brolucizumab treatment for exudative age-related macular degenerationSeigo Yoneyama, Yoichi Sakurada, Yoshiko Fukuda, et al.
Journal of Glaucoma|December 11, 2012
Comparison of a remote operating slit-lamp microscope system with a conventional slit-lamp microscope system for examination of trabeculectomy eyesKenji Kashiwagi, Naohiko Tanabe, Kentaro Go, et al.
Scientific Reports|March 8, 2017
Incidence and risk factors of retreatment after three-monthly aflibercept therapy for exudative age-related macular degenerationWataru Kikushima, Yoichi Sakurada, Seigo Yoneyama, et al.
Journal of Glaucoma|October 16, 2008
High prevalence of anxiety and depression in patients with primary open-angle glaucomaFumihiko Mabuchi, Kimio Yoshimura, Kenji Kashiwagi, et al.
Retina (Philadelphia, Pa.)|January 9, 2016
GENETIC FACTORS ASSOCIATED WITH CHOROIDAL VASCULAR HYPERPERMEABILITY AND SUBFOVEAL CHOROIDAL THICKNESS IN POLYPOIDAL CHOROIDAL VASCULOPATHYSeigo Yoneyama, Yoichi Sakurada, Wataru Kikushima, et al.
Genes|July 29, 2025
Genetic Factors Associated with Intraocular Inflammation After Brolucizumab Administration in Patients with Exudative Age-Related Macular DegenerationSeigo Yoneyama, Yoichi Sakurada, Taiyo Shijo, et al.
Ophthalmic Genetics|September 3, 2015
Risk Factors for Second Eye Involvement in Eyes with Unilateral Polypoidal Choroidal VasculopathyYasushi Tateno, Yoichi Sakurada, Seigo Yoneyama, et al.
Ophthalmic Research|December 5, 2014
Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degenerationYoichi Sakurada, Yuki Nakamura, Seigo Yoneyama, et al.
Pageof 7